Related Experiment Videos
Mast cells: a unique source of renin
Randi B Silver1, Alicia C Reid, Christina J Mackins
1Department of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA. rbsilve@med.cornell.edu
Summary
Mast cells produce renin, establishing a unique local renin-angiotensin system. This finding suggests targeting mast cells could help manage angiotensin II-related conditions.
Area of Science:
- Cardiovascular Biology
- Immunology
- Endocrinology
Background:
- The traditional renin-angiotensin system (RAS) plays a key role in blood pressure regulation.
- Evidence suggests the existence of independent, tissue-specific RAS pathways.
- Mast cells are immune cells with diverse functions, including roles in inflammation and tissue remodeling.
Purpose of the Study:
- To investigate whether mast cells contribute to local renin-angiotensin systems.
- To determine if mast cells synthesize and release active renin.
- To explore the potential role of mast cell-derived renin in cardiac angiotensin II formation.
Main Methods:
- Utilized renin-specific antibodies to detect renin in cardiac mast cells.
- Employed RT-PCR and immunoblotting to confirm renin expression and presence in the HMC-1 human mast cell line.
- Performed immunocytochemical analyses to localize renin protein within mast cells.
- Assessed the activity and synthesis of renin released from HMC-1 cells.
Main Results:
- Cardiac mast cells were identified as a source of renin.
- The human mast cell line HMC-1 expresses renin, with its RT-PCR product showing 100% homology to Homo sapiens renin.
- HMC-1 cells contain active renin protein and are capable of synthesizing renin.
- Mast cells are strategically located near cardiac myocytes and nerves expressing angiotensin II receptors.
Conclusions:
- Mast cells constitute a unique extrarenal renin-angiotensin system.
- Mast cell-derived renin may be crucial for local angiotensin II generation in the heart.
- These findings offer a new paradigm for understanding tissue-specific RAS and suggest targeting mast cells for managing angiotensin II-related disorders.